BCAB
Price
$0.48
Change
+$0.02 (+4.35%)
Updated
Jun 6 closing price
Capitalization
26.68M
60 days until earnings call
CRSP
Price
$41.86
Change
+$3.29 (+8.53%)
Updated
Jun 6 closing price
Capitalization
3.33B
64 days until earnings call
Interact to see
Advertisement

BCAB vs CRSP

Header iconBCAB vs CRSP Comparison
Open Charts BCAB vs CRSPBanner chart's image
BioAtla
Price$0.48
Change+$0.02 (+4.35%)
Volume$274.2K
Capitalization26.68M
CRISPR Therapeutics AG
Price$41.86
Change+$3.29 (+8.53%)
Volume$4.73M
Capitalization3.33B
BCAB vs CRSP Comparison Chart
Loading...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCAB vs. CRSP commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Buy and CRSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (BCAB: $0.39 vs. CRSP: $37.22)
Brand notoriety: BCAB and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 14% vs. CRSP: 76%
Market capitalization -- BCAB: $26.68M vs. CRSP: $3.33B
BCAB [@Biotechnology] is valued at $26.68M. CRSP’s [@Biotechnology] market capitalization is $3.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCAB and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • BCAB’s TA Score: 5 bullish, 5 bearish.
  • CRSP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than BCAB.

Price Growth

BCAB (@Biotechnology) experienced а +1.94% price change this week, while CRSP (@Biotechnology) price change was +0.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

BCAB is expected to report earnings on Aug 07, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.33B) has a higher market cap than BCAB($26.7M). CRSP YTD gains are higher at: -5.424 vs. BCAB (-34.100). BCAB has higher annual earnings (EBITDA): -85.17M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. BCAB (56.5M). BCAB has less debt than CRSP: BCAB (1.25M) vs CRSP (224M). CRSP has higher revenues than BCAB: CRSP (35M) vs BCAB (11M).
BCABCRSPBCAB / CRSP
Capitalization26.7M3.33B1%
EBITDA-85.17M-447.31M19%
Gain YTD-34.100-5.424629%
P/E RatioN/AN/A-
Revenue11M35M31%
Total Cash56.5M1.9B3%
Total Debt1.25M224M1%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABCRSP
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
88%
Bearish Trend 12 days ago
85%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
77%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
86%
Advances
ODDS (%)
Bullish Trend 27 days ago
81%
Bullish Trend 24 days ago
80%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 26 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
83%
Aroon
ODDS (%)
Bullish Trend 12 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with NVO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then NVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+2.18%
NVO - BCAB
40%
Loosely correlated
-2.61%
DNLI - BCAB
38%
Loosely correlated
-1.29%
CRSP - BCAB
38%
Loosely correlated
-0.92%
GALT - BCAB
37%
Loosely correlated
-1.53%
CTMX - BCAB
37%
Loosely correlated
+12.94%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.92%
RXRX - CRSP
72%
Closely correlated
+0.11%
BEAM - CRSP
72%
Closely correlated
-0.88%
NTLA - CRSP
69%
Closely correlated
+3.59%
ABCL - CRSP
62%
Loosely correlated
+3.03%
ALLO - CRSP
61%
Loosely correlated
+5.56%
More